Multimethod feasibility evaluation of smoking cessation intervention for patients receiving opioid agonist therapy

Participant retention and qualitative results support the feasibility of the tested intervention, indicating that implementing integrated smoking cessation treatments in opioid agonist therapy clinics was feasible and acceptable to patients. The low number of participants quitting indicated low feasibility for smoking cessation. Simultaneously, the more than halving of the number of cigarettes smoked suggests that the progression of the intervention should have a reduction in the number of cigarettes smoked as the primary aim. However, the impact of this intervention requires thorough evaluation through a sufficiently powered randomised controlled trial.

Authors

Institutions

Publication Details

Journal
Pilot and Feasibility Studies
Published
2025-10-31
DOI
https://doi.org/10.1186/s40814-025-01717-2
Primary Topic
Smoking Behavior and Cessation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multimethod feasibility evaluation of smoking cessation intervention for patients receiving opioid agonist therapy

Maren Borsheim Bergsaker, Marianne Larssen, Eivin Dahl, Jan Tore Daltveit et al.
Pilot and Feasibility Studies
Smoking Behavior and Cessation
article

Multimethod feasibility evaluation of smoking cessation intervention for patients receiving opioid agonist therapy

Maren Borsheim Bergsaker, Marianne Larssen, Eivin Dahl, Jan Tore Daltveit, Tone Lise Eielsen, Christine Sundal, Torhild Fiskå, Trude Fondenes, Vibeke Bråthen Buljovcic, Eirik Holder, Tesfaye Madebo, Jørn Henrik Vold, Ewa Joanna Wilk, Siv-Elin Leirvåg Carlsen, Marianne Cook Pierron, Torgeir Gilje Lid, Einar Furulund, Beate Haga Trettenes, Karl Trygve Druckrey-Fiskaaen, Lars Thore Fadnes, Mari Thoresen Soot
article en

Abstract

Participant retention and qualitative results support the feasibility of the tested intervention, indicating that implementing integrated smoking cessation treatments in opioid agonist therapy clinics was feasible and acceptable to patients. The low number of participants quitting indicated low feasibility for smoking cessation. Simultaneously, the more than halving of the number of cigarettes smoked suggests that the progression of the intervention should have a reduction in the number of cigarettes smoked as the primary aim. However, the impact of this intervention requires thorough evaluation through a sufficiently powered randomised controlled trial.

Pilot and Feasibility StudiesVol. 11(1)
Stavanger University Hospital (NO), Haukeland University Hospital (NO), Rogaland Training & Education Centre (NO), University of Bergen (NO), University of Stavanger (NO)
Universitetet i Bergen
Openalex Percentile: Top 60%
Smoking Behavior and Cessation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Multimethod feasibility evaluation of smoking cessation intervention for patients receiving opioid agonist therapy — Maren Borsheim Bergsaker, Marianne Larssen, et al. · Pilot and Feasibility Studies (2025) | TGRS Research Map | TGRS